ArticleeLife2024

Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.

Ling Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.